Human Envelop VLP Control (VLP-HM00C)
Catalog: VLP-HM00C
Order now get it on
Product Description | Recombinant Human Envelop VLP Control is expressed from HEK293. Human Envelop VLP Control is formed by self-assembly of envelop/capsid proteins from viruses, which is pure viral protein particle structure without the displayed proteins. Human Envelop VLP Control can be used as isoytype control for VLPs displaying membrane proteins in various applications. |
Product Background |
VLPs are formed by spontaneous interaction between one or more viral structural capsid proteins to form the final structure. VLPs are structurally and visually similar to live viruses but lack either a complete virus genome or lack the entire virus genome[1]. The envelop VLP control is pure viral protein particle structure without the displayed proteins, which can be used as control for the activity assay of the envelope VLP display proteins. |
Product Category |
Recombinant Protein |
Target |
Envelop VLP Control |
Synonyms | Gag polyprotein; Pr55Gag; MA; CA; SP1; p2; nc; SP2; p1; p6-gag |
Species |
Human |
Express System |
HEK293 |
Purity | > 95% as determined by HPLC |
Endotoxin | Less than 1EU per ug by the LAL method. |
Form | Liquid |
Shipping | Shipped with dry ice. |
Formulation | Supplied as 0.22um filtered solution in PBS (pH 7.4). |
Stability And Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
You may also be interested in
View more associated products